Literature DB >> 10608590

Dobutamine-stress electrocardiographically gated positron emission tomography for detection of viable but dysfunctional myocardium.

H Yamagishi1, K Akioka, K Hirata, Y Sakanoue, I Toda, M Yoshiyama, M Teragaki, K Takeuchi, J Yoshikawa, H Ochi.   

Abstract

PURPOSE: This study was performed to determine whether low-dose dobutamine stress electrocardiography (ECG)-gated fluorine-18 fluorodeoxyglucose (FDG)-positron emission tomography (PET) can assess wall motion and identify myocardium without contractile reserve despite preserved FDG uptake.
METHODS: Fifty-three patients with myocardial infarction and normal sinus rhythm underwent ECG-gated FDG-PET and transthoracic echocardiography. Wall motion of 10 segments of the left ventricle was graded as normal, hypokinetic, or akinetic/dyskinetic.
RESULTS: In 365 (76%) of 480 segments, assessment of wall motion was concordant between the 2 modalities. In 30 patients dobutamine-stress ECG-gated FDG-PET was performed. In 13 (50%) of 26 dysfunctional segments with normal FDG uptake, 16 (36%) of 44 dysfunctional segments with mildly reduced FDG uptake and 12 (25%) of 48 dysfunctional segments with moderately reduced FDG uptake, wall motion was improved by dobutamine infusion.
CONCLUSION: Assessment of left ventricular wall motion with ECG-gated FDG-PET is feasible, and dobutamine stress ECG-gated FDG-PET can simultaneously identify metabolic viability and contractile reserve.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10608590     DOI: 10.1016/s1071-3581(99)90100-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  28 in total

1.  Quantitative analysis of regional wall motion by gated myocardial positron emission tomography: validation and comparison with left ventriculography.

Authors:  K Yamashita; N Tamaki; Y Yonekura; H Ohtani; H Saji; T Mukai; H Kambara; C Kawai; T Ban; J Konishi
Journal:  J Nucl Med       Date:  1989-11       Impact factor: 10.057

2.  Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography.

Authors:  L A Piérard; C M De Landsheere; C Berthe; P Rigo; H E Kulbertus
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

3.  Inotropic contractile reserve: a useful predictor of increased 5 year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction.

Authors:  R W Nesto; L H Cohn; J J Collins; J Wynne; L Holman; P F Cohn
Journal:  Am J Cardiol       Date:  1982-07       Impact factor: 2.778

4.  Regional wall thickening of left ventricle evaluated by gated positron emission tomography in relation to myocardial perfusion and glucose metabolism.

Authors:  K Yamashita; N Tamaki; Y Yonekura; H Ohtani; Y Magata; R Nohara; H Kambara; C Kawai; T Ban; J Konishi
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

5.  Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration.

Authors:  R Bolli; W X Zhu; M L Myers; C J Hartley; R Roberts
Journal:  Am J Cardiol       Date:  1985-12-01       Impact factor: 2.778

6.  Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT.

Authors:  E G DePuey; K Nichols; C Dobrinsky
Journal:  J Nucl Med       Date:  1993-11       Impact factor: 10.057

7.  Gated SPECT with technetium-99m-sestamibi for assessment of myocardial perfusion abnormalities.

Authors:  F Mannting; M G Morgan-Mannting
Journal:  J Nucl Med       Date:  1993-04       Impact factor: 10.057

8.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

9.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.

Authors:  K Hamacher; H H Coenen; G Stöcklin
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

10.  Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease.

Authors:  P Perrone-Filardi; L Pace; M Prastaro; F Piscione; S Betocchi; F Squame; P Vezzuto; A Soricelli; C Indolfi; M Salvatore
Journal:  Circulation       Date:  1995-05-15       Impact factor: 29.690

View more
  2 in total

1.  Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium.

Authors:  H Yamagishi; K Akioka; K Hirata; Y Sakanoue; I Toda; M Yoshiyama; M Teragaki; K Takeuchi; J Yoshikawa; H Ochi
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

2.  Gated fluorine 18 fluorodeoxyglucose positron emission tomography: determination of global and regional left ventricular function and myocardial tissue characterization.

Authors:  George Saab; Robert A Dekemp; Heikki Ukkonen; Terrence D Ruddy; Guido Germano; Robert S B Beanlands
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.